ストックスクリーナーアプリを入手
57.67
3.43%
-2.05
プレマーケット:
58.32
0.65
+1.13%
前日終値:
$59.72
開ける：
$61.045
24時間の取引高:
4.46M
Relative Volume:
1.82
時価総額：
$7.19B
収益：
$692.26M
当期純損益:
$-512.41M
株価収益率:
-13.60
EPS:
-4.24
ネットキャッシュフロー:
$-274.36M
1週間 パフォーマンス:
+0.84%
1か月 パフォーマンス:
-6.07%
6か月 パフォーマンス:
+23.38%
1年 パフォーマンス:
+155.63%
1日の値動き範囲:
$55.38
$61.16
1週間の範囲:
$55.38
$61.68
52週間の値動き範囲:
$20.14
$68.00
Guardant Health Inc Stock (GH) Company Profile
GH を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
GH
Guardant Health Inc
|
57.67 | 7.45B | 692.26M | -512.41M | -274.36M | -4.24 |
|
TMO
Thermo Fisher Scientific Inc
|
468.00 | 177.38B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
185.91 | 135.85B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
627.17 | 51.87B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
124.38 | 35.70B | 6.79B | 1.22B | 1.09B | 4.26 |
|
IQV
Iqvia Holdings Inc
|
181.24 | 31.70B | 15.70B | 1.24B | 2.01B | 6.91 |
Guardant Health Inc Stock (GH) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-09-22 | 再開されました | Wells Fargo | Overweight |
| 2025-04-10 | 開始されました | Mizuho | Outperform |
| 2025-01-23 | 開始されました | Barclays | Overweight |
| 2024-06-28 | アップグレード | Guggenheim | Neutral → Buy |
| 2024-06-03 | 再開されました | Jefferies | Buy |
| 2024-04-24 | 再開されました | Craig Hallum | Buy |
| 2023-12-14 | 開始されました | Guggenheim | Neutral |
| 2023-12-13 | 開始されました | Wolfe Research | Peer Perform |
| 2023-11-13 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2023-09-28 | 開始されました | Bernstein | Outperform |
| 2023-09-27 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2023-07-05 | 再開されました | JP Morgan | Overweight |
| 2023-05-26 | アップグレード | Citigroup | Neutral → Buy |
| 2023-05-05 | 開始されました | UBS | Buy |
| 2023-03-09 | ダウングレード | Citigroup | Buy → Neutral |
| 2023-01-05 | 開始されました | Scotiabank | Sector Outperform |
| 2022-11-01 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2022-10-19 | 開始されました | Craig Hallum | Buy |
| 2022-10-06 | 開始されました | Stephens | Overweight |
| 2022-08-25 | 開始されました | Credit Suisse | Outperform |
| 2022-06-03 | 開始されました | Piper Sandler | Overweight |
| 2022-04-28 | 再開されました | BTIG Research | Buy |
| 2022-02-24 | 繰り返されました | Canaccord Genuity | Buy |
| 2022-02-24 | 繰り返されました | Citigroup | Buy |
| 2022-02-24 | 繰り返されました | Cowen | Outperform |
| 2022-02-24 | 繰り返されました | Morgan Stanley | Overweight |
| 2022-02-24 | 繰り返されました | SVB Leerink | Outperform |
| 2022-02-24 | 繰り返されました | Stifel | Buy |
| 2022-02-24 | 繰り返されました | Wells Fargo | Overweight |
| 2021-10-15 | 再開されました | Cowen | Outperform |
| 2021-06-15 | 開始されました | Raymond James | Mkt Perform |
| 2021-06-03 | 開始されました | Goldman | Buy |
| 2021-05-25 | 開始されました | Wells Fargo | Overweight |
| 2021-01-11 | 開始されました | Stifel | Buy |
| 2020-09-09 | 開始されました | Morgan Stanley | Overweight |
| 2020-06-12 | 開始されました | BTIG Research | Buy |
| 2020-02-21 | 開始されました | Guggenheim | Buy |
| 2020-01-07 | 開始されました | Citigroup | Buy |
| 2019-08-07 | 繰り返されました | Canaccord Genuity | Buy |
| 2019-04-16 | 開始されました | Canaccord Genuity | Buy |
| 2019-04-10 | アップグレード | BofA/Merrill | Neutral → Buy |
| 2019-02-28 | 繰り返されました | BofA/Merrill | Neutral |
| 2018-10-29 | 開始されました | BofA/Merrill | Neutral |
| 2018-10-29 | 開始されました | JP Morgan | Overweight |
| 2018-10-29 | 開始されました | William Blair | Outperform |
すべてを表示
Guardant Health Inc (GH) 最新ニュース
Guardant Health Hosts Investor Day in NYC - TipRanks
Guardant Health and Quest partner to expand blood-based cancer test - Investing.com Canada
Guardant joins Quest to widen access to Shield (GH:NASDAQ) - Seeking Alpha
Guardant Health (NASDAQ:GH) Shares Down 4%What's Next? - MarketBeat
Guardant Health (GH) Partners with Quest Diagnostics for Blood T - GuruFocus
Guardant Health and Quest Diagnostics Announce Strategic Collaboration to Broaden Access to Guardant’s Shield™ Blood-based Screening Test in the United States - Yahoo Finance
United States Liquid Biopsy Market Set for Breakthrough Growth - openPR.com
Strs Ohio Purchases New Stake in Guardant Health, Inc. $GH - MarketBeat
Guardant Health (GH) Stock Is Up, What You Need To Know - TradingView
Guardant Health stock rating reiterated as Buy by UBS ahead of Analyst Day - Investing.com
UPC sees next life sciences case as Guardant sues Sophia Genetics - JUVE Patent
CCORF Maintains Guardant Health(GH.US) With Buy Rating, Maintains Target Price $65 - 富途牛牛
Guardant Health (NASDAQ:GH) Raised to "Strong-Buy" at Wells Fargo & Company - MarketBeat
BTIG reiterates Buy rating on Guardant Health stock ahead of Analyst Day - Investing.com Canada
Wells Fargo Initiates Coverage on Guardant Health (GH) with Over - GuruFocus
BTIG Maintains Guardant Health(GH.US) With Buy Rating, Maintains Target Price $70 - 富途牛牛
Guardant Health (NASDAQ:GH) Given Buy Rating at BTIG Research - MarketBeat
BTIG Reiterates 'Buy' Rating for Guardant Health (GH) | GH Stock News - GuruFocus
Aug Sectors: Is Guardant Health Inc. impacted by rising ratesWeekly Trend Recap & Risk Controlled Daily Plans - خودرو بانک
Intech Investment Management LLC Boosts Position in Guardant Health, Inc. $GH - MarketBeat
VA Extends Coverage for Revolutionary Blood-Based Colorectal Cancer Screening Test - Goldsboro Daily News
RSI Check: How does Guardant Health Inc compare to its peersTrade Risk Report & Expert Verified Movement Alerts - خودرو بانک
Guardant Health, Inc. (NASDAQ:GH) Receives $58.24 Consensus Target Price from Analysts - MarketBeat
VIX Spike: Does Modine Manufacturing Company have a sustainable dividendCPI Data & Stepwise Entry and Exit Trade Signals - khodrobank.com
US Market Wrap: Is now the right time to enter Guardant Health IncBuy Signal & Daily Stock Trend Reports - خودرو بانک
Medina Manuel Hidalgo Sells 2,165 Shares of Guardant Health (NASDAQ:GH) Stock - MarketBeat
Guardant Health Inc. (GH) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Market Rankings: Can Guardant Health Inc navigate macro headwindsJuly 2025 News Drivers & Long-Term Growth Plans - khodrobank.com
Market Outlook: Can Guardant Health Inc. maintain sales growthWeekly Trend Summary & Weekly Momentum Stock Picks - خودرو بانک
Testing & Diagnostics Services Q2 Earnings: Guardant Health (NASDAQ:GH) is the Best in the Biz - Yahoo Finance
UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC Acquires 164,263 Shares of Guardant Health, Inc. $GH - MarketBeat
RSI Check: Can Guardant Health Inc. be recession proof2025 EndofYear Setup & Risk Managed Investment Entry Signals - khodrobank.com
Q2 Earnings Recap: Guardant Health (NASDAQ:GH) Tops Testing & Diagnostics Services Stocks - Yahoo Finance
Guardant Health (GH) director Potter sells $1446 in stock By Investing.com - Investing.com Australia
Guardant Health (GH) director Potter sells $1446 in stock - Investing.com
Jobs Data: Can Guardant Health Inc maintain its current growth rateQuarterly Profit Report & Real-Time Volume Spike Alerts - خودرو بانک
Aug Update: What is the implied volatility of Guardant Health IncPortfolio Gains Summary & Daily Market Momentum Tracking - خودرو بانک
Rhumbline Advisers Has $7.47 Million Stock Position in Guardant Health, Inc. $GH - MarketBeat
Guardant Health announces prelim Q4 revenue above estimate - MSN
Patterns Watch: How volatile is Guardant Health Inc. stock2025 Trading Volume Trends & Real-Time Sentiment Analysis - khodrobank.com
Guardant Health (NASDAQ:GH) Shares Gap Down Following Insider Selling - MarketBeat
Aug Sentiment: Does Guardant Health Inc. meet Warren Buffett’s criteriaQuarterly Market Summary & Safe Capital Investment Plans - خودرو بانک
Volume Summary: Is Guardant Health Inc. stock showing strong momentumTrade Risk Report & Fast Moving Stock Watchlists - khodrobank.com
SWS Partners Sells 16,071 Shares of Guardant Health, Inc. $GH - MarketBeat
Guardant Health (NASDAQ:GH) CEO Sells $17,835,000.00 in Stock - MarketBeat
Rally Mode: Can Guardant Health Inc keep up with sector leadersWeekly Market Outlook & Free Community Consensus Stock Picks - خودرو بانک
Guardant Health Inc (GH) 財務データ
収益
当期純利益
現金流量
EPS
2.20%
大文字化:
|
ボリューム (24 時間):